James S. Wilmott

Researcher Next ID · RN-004641

Researcher · Medicine

Sydney, Australia

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Cancer Immunotherapy and Biomarkers

Melanoma and MAPK Pathways

Immunotherapy and Immune Responses

Cutaneous Melanoma Detection and Management

CAR-T cell therapy research

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
Cancer Cell · 2019 · https://doi.org/10.1016/j.ccell.2019.01.003
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Clinical Cancer Research · 2019 · https://doi.org/10.1158/1078-0432.ccr-19-1868
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30139-6
Whole-genome landscapes of major melanoma subtypes
Nature · 2017 · https://doi.org/10.1038/nature22071

No projects listed.